Equity Overview
Price & Market Data
Price: $334.7
Daily Change: -$0.46 / 0.14%
Daily Range: $333.0 - $335.7
Market Cap: $23,557,566,464
Daily Volume: 11,619
Performance Metrics
1 Week: 0.75%
1 Month: 1.16%
3 Months: 7.62%
6 Months: 22.10%
1 Year: 40.78%
YTD: 28.17%
Company Details
Employees: 3900
Sector: Health technology
Industry: Medical specialties
Country:
Details
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.